Chinese english Germany Japanese Korea

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Struktur
2134096-06-1
CAS-Nr.
2134096-06-1
Englisch Name:
2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)
Synonyma:
Almonertinib mesylate;2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1);Almonertinib,EGFR tyrosine kinase inhibitor,Inhibitor,HER1,ErbB-1,third-generation,HS-10296,HS 10296,orally available,Almonertinib mesylate,inhibit,Epidermal growth factor receptor,irreversible,HS10296,non-small cell lung cancer,EGFR
CBNumber:
CB89318825
Summenformel:
C31H39N7O5S
Molgewicht:
621.76
MOL-Datei:
2134096-06-1.mol
Request For Quotation

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Eigenschaften

storage temp. 
4°C, away from moisture
Löslichkeit
DMSO : 31.25 mg/mL (50.26 mM; ultrasonic and warming and heat to 60°C)

Sicherheit

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 17)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED 		+undefined-21-51877795
ivan@atkchemical.com China 32715 60
Nanjing Doge Biomedical Technology Co., Ltd 		+86-25-58227606 +86-15305155328
 sales@dogechemical.com China 4128 58
TargetMol Chemicals Inc. 		+1-781-999-5354
support@targetmol.com United States 19973 58
Chemtour Biotech Co., Ltd 		+8617327281506
 market@chemtour.com China 1471 58
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 52927 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696，15000506266 15000506266
 China 4182 55
Hubei Chuangliankangcheng Pharmaceutical Co., Ltd. 027-65388397 18164111589
 3321478047@qq.com China 1995 55
ATK CHEMICAL COMPANY LIMITED 3429815786 13301662590
 sales@atkchemical.com China 10004 55
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994
 2853530910@QQ.com China 8011 62
Shanghai Chaolan Chemical Technology Center QQ:65489617 15618227136
 info@SuperLan-chem.com China 9824 58
  • 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)
  • Almonertinib mesylate
  • Almonertinib,EGFR tyrosine kinase inhibitor,Inhibitor,HER1,ErbB-1,third-generation,HS-10296,HS 10296,orally available,Almonertinib mesylate,inhibit,Epidermal growth factor receptor,irreversible,HS10296,non-small cell lung cancer,EGFR
  • 2134096-06-1
  • C31H39N7O5S
Copyright 2019 © ChemicalBook. All rights reserved